SAN MATEO, California and READING, England, October 8 /PRNewswire/ --

Avistar Communications Corporation (Nasdaq: AVSR), a video collaboration platform provider, today announced that Beyondis, a Reading, U.K.-based distributor of Voice over IP and videoconferencing products, will offer Avistar's patent protected C3 desktop technology to its resellers throughout the U.K. This move enables Beyondis resellers to offer a deeper product line to their customers, who have been requesting desktop videoconferencing as a way to enhance their communications abilities among their employees.

ASHLAND, Massachusetts, October 8 /PRNewswire/ --

- Acceptance Will Reduce Animal Use in Cosmetics and Chemicals Testing

MatTek Corp. today announced that results of a recently completed US and European multi-laboratory "catch-up" validation study on MatTek's EpiDerm in vitro human skin tissue equivalent. The test results demonstrated the required sensitivity and specificity for EpiDerm to be accepted as a validated alternative to animal testing for determining human skin irritation by the European ECVAM Scientific Advisory Committee (ESAC).

IRVINE, California, October 8 /PRNewswire/ --

- New Game in Development

GamersFirst (http://www.gamersfirst.com), a service of K2 Network and one of today's most popular free-to-play online game publishers, announces a development partnership for an original game with A2M, the largest independent game developer in Canada.

GamersFirst and A2M will be working together on an unannounced social gaming title. This new game will be available in late 2009 and continues the pledge of GamersFirst expanding its industry presence into the development of original titles.

COPENHAGEN, October 8 /PRNewswire/ --

- Review Zanolimumab Program to be Discontinued and Headcount to be Reduced

- Summary: Genmab Announces the Results of its Portfolio Review; Zanolimumab Program to be Discontinued and the Company Will Reduce the Number of Employees

Genmab A/S (OMX: GEN) announced today that it is discontinuing development of zanolimumab (HuMax-CD4(R)). In addition, as a result of a portfolio review and assessment of the organization, Genmab is reducing its headcount by 101 positions.

TORONTO and LONDON, October 8 /PRNewswire/ --

- Former Callidus Vice President Joins Varicent to Head Varicent's Global Expansion

Varicent Software, an innovator and provider of sales performance management (SPM) solutions, today announced the appointment of Andy Armstrong as Vice President and General Manager International.

Formerly Vice President and General Manager International with Callidus Software, a leading Incentive Compensation Management Software vendor, Armstrong's remit is to drive forward the global expansion of the Toronto-based company.

Chances are that if you've even stepped near a health foods store in the past few months, you've heard tales of an amazing imported fruit claimed to be one of the greatest super-foods of our time; the Brazilian Acai/Açaí (ah-sigh-ee) berry. Rich in antioxidants and packed full of health benefits, the tiny berry sparked an obsession in the health food world, even without significant laboratory testing.

LONDON, October 8 /PRNewswire/ --

- Strengthens Expertise in Key Market and Industry Sectors, Including Pharmaceutical and Chemical

CPA, the world's top intellectual-property management specialist and a leading provider of outsourced legal support services, announced today that it has acquired renowned German patent research firm SVPG GmbH. Frankfurt-based SVPG, formerly part of Hoechst AG, has a proud history in patent research dating back more than 20 years and specialising in the pharmaceutical, chemical, life sciences, biotech, and engineering sectors.

BRUSSELS, October 8 /PRNewswire/ -- In the light of the upcoming Energy Council meeting this Friday 10 October, the European Wind Energy Association (EWEA) has sent an open letter to French Energy Minister Borloo.

EWEA expresses its concern about a proposed 'review clause' in the Renewable Energy Directive, and underlines the importance of priority grid access for renewables. The letter also addresses some of the other key issues on the table, such as the internal electricity market, grid integration and EU competitiveness.

INDIANAPOLIS and ROUSSET, France, October 8 /PRNewswire/ --

- For Doubling of Processing Power, Upgrade to AT91SAM9G20

SUNNYVALE, California, October 8 /PRNewswire/ --

Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the first CyberKnife(R) Robotic Radiosurgery System in the Kingdom of Saudi Arabia will be installed at the prestigious King Faisal Specialist Hospital and Research Center in Riyadh. It is the first CyberKnife System to be installed in the Middle East region.

King Faisal Specialist Hospital, the leading medical institution in Saudi Arabia, has the largest cancer treatment facility in the Gulf region and was established to become the premier international center for cancer research in prevention and treatment.